VideoOculograph

PhD with successful sales management, project and product marketing management experience in very fast-moving environment of technology and IT industry. 

Inventor, author of 5 successfully launched inventions with IP ownership, a serial entrepreneur with experience of the successful sale of the first business to a strategic investor.

Competences cover full marketing cycle from R&D, new product development to launch and campaign execution, brand P&L. Established network of relationships within the local sector and media space. Influential team leader in dispersed teams.

There 7,5 mil of people with nystagmus and strabismus only in Russia. Treatment of these pathologies same time is still in 95% of cases performed only by surgery, but defect of nystagmus according to statistics can return in 6 -12 months even after successful surgery and can lead to the strabismus' side appearance as the result of a surgery, while lack of treatment leads to loss of visual acuity up to blindness.

VideoOculograph allows to solve this problem just simply by programmable periodic light stimulation with no surgical risks or further long rehabilitation period.

We've developed 1st complex intelligent device for diagnostics by eye moves and pupils' reaction and noninvasive vision pathologies correction.

Technology was scientifically validated on base of leading clinics including Fedorov network medical clinic with more than 300 successfully treated patients in a result. 

Thus, it's revolutionary technology which forever will improve people' health overall as well.

According to Russian Ministry of Health data there 7,5 mil of people with nystagmus and strabismus only in Russia, 7% of children and 4% of total adult population all over the world suffering from strabismus, in every maternity hospital the innate forms of pathology for every 50th baby are revealed.  

Treatment of these pathologies same time is still in 95% of cases performed only by surgery, but defect of nystagmus according to statistics can return in 6 -12 months even after successful surgery and can lead to the strabismus' side appearance as the result of a surgery, while lack of treatment leads to loss of visual acuity up to blindness.

Same time the effectiveness of the surgery is provided directly by the accuracy of diagnostics but well-known methods of preoperative registration of involuntary eye movements based on using of methods of electro-oculography or photoelectric nystagmography don’t give objective quantitative characteristics of such movements.

VideoOculograph allows to solve this problem.

It's the 1st complex intelligent solution on the base of computer vision, AI and ML for highly reliable digital and even remote diagnostics by involuntary eye moves and pupils' reaction and noninvasive treatment of eye pathologies if such were revealed.

VideoOculograph is automatic and easy to operate with: simply turn it on, choose the diagnostic algorithm and press the start button. The protocol with diagnostic data is available even on your PC, touch pad, or smartphone through VideoOculograph mobile app already within 5 min. One can use VideoOculograph to analyze and track trends, catch changes early with unprecedented simplicity for not to let precious diagnostic data get lost.

Same time highly reliable diagnostics exam by eyes is now obtainable where you need it and any time you want. You can even test someone from any point of the world. For this it's just enough to upload to device, app. or VideoOculograph interactive platform the eyes' video from at least 120 fps camera which in fact makes Digital Personal Healthcare Concept a reality!

One can begin the treatment procedure when ready if eye pathology was revealed, heal from such eye pathologies as nystagmus or strabismus without any surgery just simply by the light.

Technology was scientifically validated on base of leading clinics including Fedorov network medical clinic ISTC «Eye microsurgery» with more than 300 successfully treated patients with nystagmus in a result.

There 7,5 mil of people with nystagmus and strabismus only in Russia. Treatment of these pathologies same time is still in 95% of cases performed only by surgery, but defect of nystagmus according to statistics can return in 6 -12 months even after successful surgery and can lead to the strabismus' side appearance as the result of a surgery, while lack of treatment leads to loss of visual acuity up to blindness.

VideoOculograph allows to solve this problem just simply by programmable periodic light stimulation with no surgical risks or further long rehabilitation period.

Our technology's been already scientifically validated on base of leading clinics including Fedorov network medical clinic ISTC «Eye microsurgery» with more than 300 successfully treated patients with nystagmus in a result.

Our goal is at least 200 european clinics with at least 100 successfully treated patients yearly by means of our technology on base of each of them up to 2023 year.

Thus, it's a revolutionary technology that forever will change the way we used to conduct vision diagnostics and treatment and will improve people's health overall as well.

There 7,5 mil of people with nystagmus and strabismus only in Russia. Treatment of them is still in 95% of cases performed only by surgery, but defect of nystagmus according to statistics can return in 6 -12 months even after successful surgery and can lead to strabismus' side appearance as the result of surgery, while lack of treatment leads to loss of visual acuity up to blindness.

VideoOculograph was started with 1 mission: redefine the way we used to conduct vision pathologies diagnostics & treatment, bring revolution in vision diagnostic & treatment and make Digital Personal Healthcare Concept a reality!

After working in ophtalmology and healthcare for a combined 70 years, developing some of the top distributed in Russia in CIS countries diagnostic solutions for vision, our founding team realized that there was a large gap in what was currently available for eye pathologies diagnostic and noninvasive treatment, and what was possible. 

Our team believed that everyone should have access to highest level of healtch care experience possible, so we formed VideoOculograph with 1 mission: redefine the way we used to conduct vision pathologies diagnostics & treatment, bring revolution in vision diagnostic & treatment.

4 years ago we've conducted first experiments with our technology and realized that we could create something unique. We managed to move on to a new level and develop the 1st device for contactless diagnostic of several diseases by involuntary eye moves & pupils' reaction. We started from vision pathologies and were lucky to discover the essential new way of noninvasive correction at least two of them such as nystagmus and strabismus.

Since that time, we developed 4 generations of prototypes from desktop configuration to portable gear with built in light system and infrared camera and conducted countless tests in order to achieve max accuracy.

Our with my co-Founder mom is well-known al over the world children surgeon-ophthalmologist with more than 30 years of surgical practice and successful inventions in the healthcare industry. She is one of our key developers and Medical Director of our venture as well.

She saw a lot of children with such problem as congenital nystagmus and wanted to have an opportunity to help them with no surgery risks or long rehabilitation period so she tasked our team to find the way how to do it the safest and most efficient way and we're lucky to achieve this.

VideoOculoraph team is comprised of MDs: surgeons-ophtalmologists and biophysicists, data scientists, mathematicians and coders, mechanical and electrical engineers. Two our key technology developers are well known surgeons-ophthalmologists with more than 30 years of surgical practice and successful inventions in healthcare industry with relevant expertise in field of development of Hardware&Software complexes for medical diagnostics.

We all bring unique expertise — from medicine to product design. What unites us? Quite simply, a desire to help people find a better way to manage their health.

During our venture, we had a lot of difficult situation such as the complexity caused by the bureaucratization of the IP rights protection process of each configuration of our technology gear but due to our mutual commitment in the success and our team expertise now our solution is protected by 10 patents already with the patent from 20th as the most recent one.

We with my co-Founder earlier also worked together on the startup and have sold our first business to our strategic investor from Seoul.

In addition to surgery correction for noninvasive treatment of nystagmus and strabismus russian product - Monobinoscope MBS-02 FORBIS (http://www.med-snab.ru/shop/part13/oftalmomiotrenazhery/monobinoskop-mbs-02/) is known. It's cost is $4150, weigh is about 20 kg. However it does not allow to conduct online high accurate computer video diagnostics of eye pathologies during the the procedures for accurate treatment effectiveness tracking and doesn't assume keeping of video base of diagnostics data of patients and machine learning approaches' using.

There are analog diagnostics systems from companies of international William Demant Holding. The nearest portable solution from one of them, Interacoustics VNG VO425 (http://www.interacoustics.com/vng), for 7780$ doesn’t allow to conduct the noninvasive correction of eye pathologies but intended only for nystagmus' diagnostics.

Thus our value proposal for target audience is 1st portable inteligent solution which allows to to do both: high reliable health diagnostics by eye moves' and pupils' reaction and noninvasive vision correction in case if needed as well with an opportunity of online accurate treatment effectiveness tracking right during the treatment procedures.

Now our technology was scientifically validated during trials on base of leading clinics including Fedorov network medical clinic ISTC «Eye microsurgery» with more than 300 successfully treated patients with nystagmus in a result. 

We've shiped our solution to 9 network medical clinics.

Our goal is at least 70 European clinics next year with at least 100 successfully treated patients by meants of our technology yearly on base of each of them and 500 clinics in 5 years.

Our goal is to help educate the world on the potential of how VideoOculograph technology can help to improve people' health and their life quality, make their lives happier, healthier, and easier—every day. 

The worldwide promotion of product is planned: the product is launched in Russia and CIS countries markets and preparing for further launch abroad starting from Switzerland, Germany and Denmark, USA and China.

Target audience:  

• Distributors of diagnostic equipment & health products: licenses sales, hardware & software complexes sales (margin profit from 45%), software sales  

• Network medical clinics, state and private health facilities: hardware & software complexes sales (margin profit from 45%)  

• Networks of consumer electronics: hardware & software complexes sales (margin profit: 100%)  

• Research institutes in Russia and abroad  

• Medical associations (ISTC "Eye microsurgery", All-Russian Ophthalmological Society etc.)  

• Enforcement authorities  

• Direct customers: hardware&software complexes sales, remote diagnostics services

Business model includes opportunity of sale of license to distributor or company's equity to investor, one of key competitors such as William Demant Holding or major international manufacturer (Carl Zeiss, Alcon, J&J, Philips, Sanofi, Huawei etc.) or strategic partner.

To bring the VideoOculograph to the vast consumer market including USA, we still have to file with the FDA while the exploratory version of the VideoOculograph is not a medical device yet for USA market and makes no medical claims, it can only be used as part of an investigation for collecting certain data in accordance with the study’s protocol.

Before VideoOculograph can become a medical device for USA market it will have to go through the FDA (Food and Drug Administration) premarket notification process. VideoOculograph eligible participants will help us by testing themself as part of a research study and giving us feedback to refine the VideoOculograph. This will happen in the framework of official clinical studies. This way we can put VideoOculograph through FDA to become an over-the-counter consumer-grade diagnostic tool.

R&D Partner: 
• Chernishevskiy National research Saratov State University (http://sgu.ru/) 
Clinical Trials Partners: 
• Fedorov Interbranch Scientific & Technical Complex «Eye microsurgery» (http://www.mntk.ru/) 
• Clinic of Eye Diseases of Razumovskiy Saratov State Medical University (http://eyeclinicsgmu.ru/) 
• Helmholtz Moscow Research Institute of Eye Diseases (http://helmholtzeyeinstitute.ru/) 
Media Partner: 
• All-Russian Society of Inventors & Rationalizes (http://www.ros-voir.ru/) 
Industrial Partner: 
• Shvabe (http://shvabe.com/en/about/) 
Funding Partner: 
• Federal Fund for Assistance to Small Innovative Enterprises in Science and Technology (http://fasie.ru/)

Target audience:  

• Distributors of diagnostic equipment & health products: licenses sales, hardware & software complexes sales (margin profit from 45%), software sales  

• Network medical clinics, state and private health facilities: hardware & software complexes sales (margin profit from 45%)  

• Networks of consumer electronics: hardware & software complexes sales (margin profit: 100%)  

• Research institutes in Russia and abroad  

• Medical associations (ISTC "Eye microsurgery", All-Russian Ophthalmological Society etc.)  

• Enforcement authorities  

• Direct customers: hardware&software complexes sales, remote diagnostics services

Business model includes opportunity of sale of license to distributor or company's equity to investor, one of key competitors such as William Demant Holding or major international manufacturer (Carl Zeiss, Alcon, J&J, Philips, Sanofi, Huawei etc.) or strategic partner.

The worldwide promotion of product is planned: the product is launched in Russia and CIS countries markets and preparing for further launch abroad starting from Switzerland, Germany and Denmark, USA and China.

Currently, we're generating revenue mostly from our 3 key customers - network medical clinics while each of them usually orders at least 8-10 devices at least once a quarter.

We raised more about $100K in grants and prize money all equity-free. For the previous year, those were $30K grant from FASIE Fund, $15K grant from Fund for Social ventures "Навстречу переменам" and 2 grants from Governor of Moscow Region and others.

Currently we're raising $350K for 14% equity to be spent on further R&D: improvement of features of new portable gear, CE/FDA certification, PCT localization in each country of our interest, serial industrial production, further product launch and its promotion to the market.

Our goal is to help educate the world on the potential of how VideoOculograph technology can help to improve people' health and their life quality, make their lives happier, healthier, and easier—every day. To do this, we need to get the word out about what we’re developing so The Elevate Prize is a good chance to make it faster - make the revolutionary in healthcare and make the Digital Personal Healhcare Concept a reality.